Prof. Timothy Lu, Prof. Jim Collins and Philip Lee ’03 co-founded Senti Bio, a biotechnology company that uses gene circuit technology to create cell and gene therapies that can sense and respond to ailments inside the body, reports Sohini Podder for Reuters. “The way I like to think about it – just like you can program a computer with different programs or different maps, we can do the same thing with medicines,” says Lu.
MIT scientists have discovered a way to watch and record the development of butterfly scales from the inside of a butterfly’s chrysalis, reports Elizabeth Gamillo for Smithsonian Magazine. “The team plans on further exploring the structure of butterfly wings and the reasoning behind the ridged design,” writes Gamillo.
Marcos Berríos ‘06, Christina Birch PhD ’15, and Christopher Williams PhD ’12 are among the ten selected to be a part of NASA’s 2021 astronaut candidate class, reports Emre Kelly for USA Today. “Flanked by T-38 Talon jets to be used over their two-year training course at Johnson Space Center in Houston, NASA officials introduces the 2021 class of six men and four women in front of their families, friends, and soon-to-be colleagues,” writes Kelly.
Marcos Berríos ‘06, Christina Birch PhD ‘15 and Christopher Williams PhD ’12 have been selected as part of NASA’s 2021 astronaut candidate class, reports WBUR’s Bill Chappell. “Alone, each candidate has ‘the right stuff,’ but together they represent the creed of our country: E pluribus unum – out of many, one,” said NASA Administrator Bill Nelson.
Marcos Berríos ‘06, Christina Birch PhD ‘15, Christopher Williams PhD ‘12 are among the ten astronauts selected for the 2021 NASA astronaut class, reports Breanna Kovatch for The Boston Globe. “The class of astronauts were selected from among 12,000 candidates and is the first class in four years,” writes Kovatch.
Researchers from MIT and the La Jolla Institute for Immunology have found a vaccine ingredient that may strengthen immune response, reports Natalie Colarossi for Newsweek. This combination-style vaccine ingredient “may boost the effectiveness of inoculations ranging from HIV to Covid-19,” writes Colarossi.
Edgar Herwick of GBH News visits the lab of Prof. Mathias Kolle to explore the science behind what causes rainbows to arc across the sky. “The sun has to be behind you. Then water in the atmosphere in front of you. And that's usually when it rains, you get that condition,” says Kolle. “Then what you also want to do is you want to look at the right spot.”
CNET science writer Monisha Ravisetti spotlights MIT researchers who have successfully recorded the scale formation of butterfly wings during its transformation. “Understanding their schematics could ultimately benefit constructed materials like windows and thermal systems and even bring an ethereal quality to textiles,” writes Ravisetti.
Popular Science reporter Hannah Seo writes that MIT researchers have developed a way to watch and record how the microscopic scales on a butterfly’s wings grow and tile themselves as the butterfly develops inside its chrysalis. The researchers hope to “use butterfly scales as inspiration for the design of new materials,” writes Seo. “Butterfly scales have other fascinating properties such as water repellency and the ability to regulate temperature.”
ARS Technica senior writer Jennifer Ouellette spotlights MIT researchers who have successfully recorded the structural growth of butterfly wings inside its chrysalis for the first time. “A lot of these stages were understood and seen before, but now we can stitch them all together and watch continuously what’s happening, which gives us more information on the detail of how scales form,” says research assistant Anthony McDougal.
Researchers from MIT and the Smithsonian Conservation Biology Institute are developing a probiotic to cure amphibian chytrid fungus in frogs, reports Jennifer Zoon for Smithsonian Magazine.
Biobot Analytics, a startup founded by Mariana Matus ‘18 and Newsha Ghaeli ‘17, has raised $20 million in funding for its work with wastewater epidemiology, reports Carey Goldberg and Janet Wu for Bloomberg News. “This past year, wastewater epidemiology changed from being an obscure niche area of science to becoming a central pillar of the response to the Covid-19 pandemic,” says Matus. “And now, in the later stages of the pandemic, it’s becoming a central pillar of preparing for the next pandemic.”
Nature reporter Eric Bender spotlights MIT startup Kytopen, which has developed a microfluidic platform to create induced pluripotent stem (iPS) cells and other forms of cell therapy. We want to do minimally invasive surgery,” says Kytopen co-founder Prof. Cullen Buie.
New York Times reporter Steve Lohr spotlights the origin and history of MIT startup Gingko Bioworks, a synthetic biology company founded with a “shared belief that biology could be made more like computing with reusable code and standard tools instead of the bespoke experiments of traditional biology." Jason Kelly ’03, PhD ’08, one of the founders of MIT startup Ginkgo Bioworks and the company’s chief executive, explains that “the ultimate goal for Ginkgo is to make it as easy to program a cell as it is to program a computer.”
A new tabletop device developed by researchers from MIT and other institutions can identify Covid-19 variants in a person’s saliva, reports CBS Boston. “We tried to limit the number of user steps to make sure it was as easy as possible,” explains graduate student Devora Najjar.